429 related articles for article (PubMed ID: 19064987)
21. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
22. Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.
Advani R; Rosenberg SA; Horning SJ
J Clin Oncol; 2004 Apr; 22(8):1454-9. PubMed ID: 15024027
[TBL] [Abstract][Full Text] [Related]
23. Acute leukemia and myelodysplasia in patients with a Philadelphia chromosome negative chronic myeloproliferative disorder treated with hydroxyurea alone or with hydroxyurea after busulphan.
Nielsen I; Hasselbalch HC
Am J Hematol; 2003 Sep; 74(1):26-31. PubMed ID: 12949887
[TBL] [Abstract][Full Text] [Related]
24. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
25. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
[TBL] [Abstract][Full Text] [Related]
26. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
[TBL] [Abstract][Full Text] [Related]
27. Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Brown JR; Yeckes H; Friedberg JW; Neuberg D; Kim H; Nadler LM; Freedman AS
J Clin Oncol; 2005 Apr; 23(10):2208-14. PubMed ID: 15753460
[TBL] [Abstract][Full Text] [Related]
28. Waldenstrom's macroglobulinemia: a retrospective analysis of 40 patients from 1972 to 2001.
Ngan S; Rohatiner AZ; Matthews J; Williams A; Amess JA; Norton A; Lister TA
Semin Oncol; 2003 Apr; 30(2):236-8. PubMed ID: 12720143
[TBL] [Abstract][Full Text] [Related]
29. Malignant myeloid transformation in congenital forms of neutropenia.
Freedman MH; Alter BP
Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
[TBL] [Abstract][Full Text] [Related]
30. [Long-term follow-up of malignant clonal evolution in patients with acquired aplastic anemia].
Li XX; Ge ML; Shi J; Feng XY; Shao YQ; Qian LS; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):463-7. PubMed ID: 22213866
[TBL] [Abstract][Full Text] [Related]
31. Lymphoplasmacytic lymphoma/Waldenström macroglobulinemia associated with Hodgkin disease. A report of two cases.
Rosales CM; Lin P; Mansoor A; Bueso-Ramos C; Medeiros LJ
Am J Clin Pathol; 2001 Jul; 116(1):34-40. PubMed ID: 11447749
[TBL] [Abstract][Full Text] [Related]
32. Treatment-related myelodysplasia following fludarabine combination chemotherapy.
Tam CS; Seymour JF; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Westerman D
Haematologica; 2006 Nov; 91(11):1546-50. PubMed ID: 17082012
[TBL] [Abstract][Full Text] [Related]
33. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
[TBL] [Abstract][Full Text] [Related]
34. Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature.
Swolin B; Rödjer S; Westin J
Ann Hematol; 2008 Jun; 87(6):467-74. PubMed ID: 18351338
[TBL] [Abstract][Full Text] [Related]
35. Secondary malignancies in a child with Hodgkin's disease: T-cell lymphoma and myelodysplastic syndrome evolving into acute nonlymphoblastic leukaemia.
Polychronopoulou S; Panagiotou JP; Papadakis T; Mavrou A; Anagnostou D; Haidas S
Med Pediatr Oncol; 1996 May; 26(5):359-66. PubMed ID: 8614370
[TBL] [Abstract][Full Text] [Related]
36. The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experience.
Menes M; Vakiani E; Keller CE; Ho EK; Colovai A; Nichols G; Diuguid D; Mears JG; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2007 Jan; 31(1):59-65. PubMed ID: 16787662
[TBL] [Abstract][Full Text] [Related]
37. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
[TBL] [Abstract][Full Text] [Related]
38. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
Hake CR; Graubert TA; Fenske TS
Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
[TBL] [Abstract][Full Text] [Related]
39. Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.
Morra E; Varettoni M; Tedeschi A; Arcaini L; Ricci F; Pascutto C; Rattotti S; Vismara E; Paris L; Cazzola M
Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):700-3. PubMed ID: 24070824
[TBL] [Abstract][Full Text] [Related]
40. Incidence and characteristics of CD4(+)/HLA DRhi dendritic cell malignancies.
Bueno C; Almeida J; Lucio P; Marco J; Garcia R; de Pablos JM; Parreira A; Ramos F; Ruiz-Cabello F; Suarez-Vilela D; San Miguel JF; Orfao A
Haematologica; 2004 Jan; 89(1):58-69. PubMed ID: 14754607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
